More Gemini Features Coming to Google TV
Google TV integrates Gemini AI for image/video generation, enhances Google Photos, and adds a dedicated YouTube Shorts feed to the homepage.
Read moreSince the accidental discovery of penicillin in 1928, medical researchers have been dedicated to finding other life-saving antibiotics and reusing them for humans. However, some bacteria develop resistance to drugs in less than a year after their introduction. For decades, no major new antibiotics have been developed.
Nature has become the main source of current antibiotics. Over millions of years, plants, fungi, and other organisms have evolved various clever chemical defenses against bacteria, so chemists have been tirelessly replicating them. For example, penicillin is produced by a fungus and kills bacteria by weakening their cell walls. Its discoverer, Alexander Fleming, once said, "I did not invent penicillin, I discovered it." Cesar de la Fuente, a professor at the University of Pennsylvania, believes that nature may have lost its inspiration, and now it is time to use 21st-century methods to search for new drugs: artificial intelligence.
In the laboratory at the University of Pennsylvania, Fuente and his team use computer algorithms and artificial intelligence to design and improve new drugs, screening for chemical components that have the potential to penetrate bacterial defenses.
At the Perelman School of Medicine at the University of Pennsylvania, De la Fuente's exploration of new antibiotics begins with the building blocks of life, amino acids, but he combines them in ways that nature has never thought of.
In a sense, this is a huge mathematical problem. The ways in which 20 core amino acids can be arranged into short peptide chains are potentially more numerous than the number of stars in the universe, but in nature, only 1% of these combinations exist, and only two have become actual antibiotics. De la Fuente hopes to discover new antibiotics beneficial to humans among all these combinations.In one project in the laboratory, Fuente automated the process and created a system that incorporates some principles of artificial intelligence. The system generates molecules, runs computer simulations, and then guides robotic arms to manufacture and test the winners' ability to combat live bacteria. The most effective combinations are fed back into the model for the next round of screening, resulting in the optimal combination.
In a recent study, he and his colleagues started with a naturally occurring antibiotic: a peptide found in pomegranate seeds. This peptide has weak antimicrobial properties, and they were interested in two features of this peptide. It contains certain positively charged amino acids, which means they will be attracted to the negatively charged membranes of bacteria. It includes other amino acids with chemical properties that allow them to interact with and disrupt these lipid membranes.If scientists can randomly generate hundreds of analogs of this natural peptide on a computer (by cutting it into fragments, reassembling them, and swapping different amino acids in several positions), perhaps the interaction between these two features can be optimized, resulting in a stronger microbial attack.
The researchers screened 15 of the hundreds of compounds generated by this algorithm and prepared them in the laboratory for bacterial testing. Indeed, several showed enhanced antibacterial activity, with one in particular standing out. They called it Punicalagin 2, and while it is still a peptide, it is significantly different from its natural source, with an unusually high content of arginine amino acids. Fuente and his team are working to make it the next penicillin.
Google TV integrates Gemini AI for image/video generation, enhances Google Photos, and adds a dedicated YouTube Shorts feed to the homepage.
Read moreAlphabet Q1 paid subscribers reached 350M, fueled by YouTube & Google One. YouTube ad revenue slightly missed at $9.88B amid Premium growth. Total Q1 revenue hit $109.9B, beating forecasts.
Read moreAnthropic releases Claude connectors for Adobe, Blender, and Ableton, enabling AI workflow automation and app control. It also sponsors the Blender Development Foundation.
Read moreApple introduces an App Store model splitting 12-month plans into monthly installments. On iOS 26.4+, it lowers upfront costs without reducing total price, adding billing tracking.
Read moreGoogle launches Aadhaar digital IDs in Wallet for India, enabling secure QR/NFC verification. A phased partner rollout targets key sectors, while passport-based credentials expand globally.
Read moreYouTube tests "Ask YouTube," an AI tool blending text and video for complex queries. Initially for US Premium users, it supports interactive follow-ups, expanding Google's AI search.
Read moreGoogle grants US DoD classified AI access, joining OpenAI and xAI in defense deals amid Anthropic's dispute. Contractual safeguards against surveillance and lethal weapons remain unenforceable.
Read moreMistral AI launches Workflows, a Temporal-powered orchestration platform for secure, Python-driven enterprise AI automation featuring human-in-the-loop approvals.
Read moreCustom subliminal audio maker

AI Social Media Manager

AI Search Visibility

Workout and Calorie Tracker
Stock research platform

AI interview assistant

Scientific figure generator

AI courses with real code